139 related articles for article (PubMed ID: 29061672)
1. miR-6883 Family miRNAs Target CDK4/6 to Induce G
Lulla AR; Slifker MJ; Zhou Y; Lev A; Einarson MB; Dicker DT; El-Deiry WS
Cancer Res; 2017 Dec; 77(24):6902-6913. PubMed ID: 29061672
[TBL] [Abstract][Full Text] [Related]
2. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
[TBL] [Abstract][Full Text] [Related]
3. Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer.
Shao Y; Shen YQ; Li YL; Liang C; Zhang BJ; Lu SD; He YY; Wang P; Sun QL; Jin YX; Ma ZL
Oncotarget; 2016 Jun; 7(23):34011-21. PubMed ID: 27049724
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory effects of three miR-129 family members on gastric cancer.
Yu X; Song H; Xia T; Han S; Xiao B; Luo L; Xi Y; Guo J
Gene; 2013 Dec; 532(1):87-93. PubMed ID: 24055727
[TBL] [Abstract][Full Text] [Related]
5. Revealing the anti-tumor effect of artificial miRNA p-27-5p on human breast carcinoma cell line T-47D.
Tseng CW; Huang HC; Shih AC; Chang YY; Hsu CC; Chang JY; Li WH; Juan HF
Int J Mol Sci; 2012; 13(5):6352-6369. PubMed ID: 22754369
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
7. MiR-124 retards bladder cancer growth by directly targeting CDK4.
Zhang T; Wang J; Zhai X; Li H; Li C; Chang J
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1072-9. PubMed ID: 25348738
[TBL] [Abstract][Full Text] [Related]
8. miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
Li S; Wang C; Yu X; Wu H; Hu J; Wang S; Ye Z
Oncol Rep; 2017 Jan; 37(1):241-248. PubMed ID: 27878260
[TBL] [Abstract][Full Text] [Related]
9. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
10. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.
Baraniskin A; Birkenkamp-Demtroder K; Maghnouj A; Zöllner H; Munding J; Klein-Scory S; Reinacher-Schick A; Schwarte-Waldhoff I; Schmiegel W; Hahn SA
Carcinogenesis; 2012 Apr; 33(4):732-9. PubMed ID: 22287560
[TBL] [Abstract][Full Text] [Related]
11. miR-19-5p Enhances Tumorigenesis in Human Colorectal Cancer Cells by Targeting TSPYL5.
Huang C; Luo H
DNA Cell Biol; 2018 Jan; 37(1):23-30. PubMed ID: 29240449
[TBL] [Abstract][Full Text] [Related]
12. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells.
Morimoto Y; Mizushima T; Wu X; Okuzaki D; Yokoyama Y; Inoue A; Hata T; Hirose H; Qian Y; Wang J; Miyoshi N; Takahashi H; Haraguchi N; Matsuda C; Doki Y; Mori M; Yamamoto H
Br J Cancer; 2020 Mar; 122(7):1037-1049. PubMed ID: 32066912
[TBL] [Abstract][Full Text] [Related]
13. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway.
Shang A; Lu WY; Yang M; Zhou C; Zhang H; Cai ZX; Wang WW; Wang WX; Wu GQ
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1754-1762. PubMed ID: 29073835
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
15. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
16. miR-124 radiosensitizes human esophageal cancer cell TE-1 by targeting CDK4.
Zhang YH; Wang QQ; Li H; Ye T; Gao F; Liu YC
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323123
[TBL] [Abstract][Full Text] [Related]
17. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
Li Q; Liang X; Wang Y; Meng X; Xu Y; Cai S; Wang Z; Liu J; Cai G
Sci Rep; 2016 May; 6():27157. PubMed ID: 27244080
[TBL] [Abstract][Full Text] [Related]
18. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
19. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
20. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]